Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$13.53 - $23.34 $138,317 - $238,604
-10,223 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$16.14 - $22.6 $2,921 - $4,090
-181 Reduced 1.74%
10,223 $231,000
Q4 2021

Feb 14, 2022

SELL
$18.64 - $36.77 $838 - $1,654
-45 Reduced 0.43%
10,404 $195,000
Q3 2021

Nov 15, 2021

BUY
$32.83 - $43.0 $7,419 - $9,718
226 Added 2.21%
10,449 $343,000
Q2 2021

Aug 16, 2021

BUY
$34.41 - $44.03 $12,525 - $16,026
364 Added 3.69%
10,223 $436,000
Q1 2021

May 14, 2021

SELL
$37.29 - $47.19 $15,027 - $19,017
-403 Reduced 3.93%
9,859 $378,000
Q4 2020

Feb 16, 2021

SELL
$34.3 - $44.09 $28,537 - $36,682
-832 Reduced 7.5%
10,262 $449,000
Q3 2020

Nov 16, 2020

BUY
$27.86 - $39.35 $1,114 - $1,574
40 Added 0.36%
11,094 $437,000
Q2 2020

Aug 14, 2020

BUY
$30.3 - $42.55 $32,360 - $45,443
1,068 Added 10.69%
11,054 $349,000
Q1 2020

May 15, 2020

SELL
$30.0 - $54.18 $15,420 - $27,848
-514 Reduced 4.9%
9,986 $352,000
Q4 2019

Feb 14, 2020

BUY
$42.29 - $52.2 $21,145 - $26,100
500 Added 5.0%
10,500 $510,000
Q4 2018

Feb 14, 2019

SELL
$25.26 - $38.43 $858 - $1,306
-34 Reduced 0.34%
10,000 $285,000
Q3 2018

Nov 14, 2018

SELL
$33.27 - $39.25 $331,568 - $391,165
-9,966 Reduced 49.83%
10,034 $393,000
Q2 2018

Aug 14, 2018

SELL
$21.73 - $33.15 $89,093 - $135,915
-4,100 Reduced 17.01%
20,000 $647,000
Q1 2018

May 15, 2018

SELL
$21.05 - $26.6 $18,945 - $23,940
-900 Reduced 3.6%
24,100 $529,000
Q4 2017

Feb 14, 2018

SELL
$23.37 - $29.26 $140,220 - $175,560
-6,000 Reduced 19.35%
25,000 $592,000
Q3 2017

Nov 14, 2017

BUY
$27.25 - $31.55 $844,750 - $978,050
31,000
31,000 $873,000

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.